Mesenchymal stem cells derived from bone marrow have recently been described to
localize to breast carcinomas and to integrate into the tumor-associated stroma. In the …

We have used in vitro and mouse xenograft models to examine the interaction between
breast cancer stem cells (CSC) and bone marrow–derived mesenchymal stem cells (MSC) …

Mesenchymal stem cells (MSCs) play a critical role in promoting cancer progression.
However, it is not clear whether MSCs are located in breast cancer tissues and correlated …

Autologous adipose tissue or adipose tissue with additive adipose-derived mesenchymal
stem cells (ADSCs) is used in the breast reconstruction of breast cancer patients who …

In the present study, we investigated whether human adipose tissue derived stem cells
(hASCs) could enhance tumor invasion and whether these hASCs could be a potential …

Abstract Introduction Mesenchymal stem cells (MSCs) are known to migrate to tumor tissues.
This behavior of MSCs has been exploited as a tumor-targeting strategy for cell-based …

Cancer-associated fibroblasts (CAFs) are highly prominent in breast tumors, but their
functional heterogeneity and origin are still largely unresolved. We report that bone marrow …

Bone metastasis is a common event during breast cancer progression. Recently,
mesenchymal stem cells (MSCs) have been implicated in the metastasis of primary …

Background Carcinoma-associated fibroblasts (CAF) are considered to contribute to tumor
growth, invasion and metastasis. However, the cell type of origin remains unknown. Since …

Cell therapy has the potential to offer novel treatment modalities for a number of diseases
including cancer, and stem cells and in particular mesenchymal stem cells (MSCs) have …